Trial Profile
A pilot study to evaluate the effect of inhaled treprostinil sodium on ventilation perfusion matching in patients with group 1 pulmonary-arterial-hypertension with concomitant chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2016
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 08 Mar 2016 New trial record